Skip to main content
. 2024 Oct 14;15:1472845. doi: 10.3389/fneur.2024.1472845

Figure 1.

Figure 1

The change in Quantitative Myasthenia Gravis score for each patient from baseline (white bar) to after the first cycle of the efgartigimod treatment (black bar). Each number on the X-axis indicates a Patient No. 10 of 14 patients (71.4%) were QMG responders (≥3 point reduction the QMG score) in the first treatment cycle.